Aromatic Amines Exert Contrasting Effects on the Anticoagulant Effect of Acetaldehyde upon APTT

The pharmacological effects of amphetamine, procaine, procainamide, DOPA, isoproterenol, and atenolol upon activated partial thromboplastin time in the absence and presence of acetaldehyde have been investigated. In the absence of acetaldehyde, amphetamine and isoproterenol exhibit a procoagulant effect upon activated partial thromboplastin time, whereas atenolol and procaine display anticoagulant effects upon activated partial thromboplastin time. DOPA and procainamide do not alter activated partial thromboplastin time. Premixtures of procaine with acetaldehyde produce an additive anticoagulant effect on activated partial thromboplastin time, suggesting independent action of these compounds upon clotting factors. Premixtures of amphetamine with acetaldehyde, as well as atenolol with acetaldehyde, generate a detoxication of the anticoagulant effect of acetaldehyde upon activated partial thromboplastin time. A similar statistically significant decrease in activated partial thromboplastin time is seen when procainamide is premixed with acetaldehyde for 20 minutes at room temperature. Premixtures of DOPA and isoproterenol with acetaldehyde do not affect an alteration in activated partial thromboplastin time relative to acetaldehyde alone. Hence, a selective interaction of atenolol, procaine, and amphetamine with acetaldehyde to produce detoxication of the acetaldehyde is suggested, undoubtedly due to the presence of amino, hydroxyl, or amide groups in these drugs.

[1]  Karin Rothschild,et al.  Comprehensive Handbook Of Alcohol Related Pathology , 2016 .

[2]  P. Poornima,et al.  Protective Effect of Neferine Against Isoproterenol-Induced Cardiac Toxicity , 2012, Cardiovascular Toxicology.

[3]  L. Vennila,et al.  Efficacy of sesamol on plasma and tissue lipids in isoproterenol-induced cardiotoxicity in wistar rats , 2012, Archives of pharmacal research.

[4]  J. Vaghasiya,et al.  Cardio protective effect of vitamin A against isoproterenol-induced myocardial infarction. , 2012, Journal of nutritional science and vitaminology.

[5]  T. Speight,et al.  An Overview of Therapeutic Interventions in Myocardial Infarction , 2012, Drugs.

[6]  Katherine Esse,et al.  Epidemic of illicit drug use, mechanisms of action/addiction and stroke as a health hazard , 2011, Brain and behavior.

[7]  A. Abbas,et al.  Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke. , 2010, Acta physiologica Hungarica.

[8]  Ru Zhou,et al.  Cardioprotective effect of matrine on isoproterenol‐induced cardiotoxicity in rats , 2010, The Journal of pharmacy and pharmacology.

[9]  P. Stanely Mainzen Prince,et al.  Preventive effect of caffeic acid on lysosomal dysfunction in isoproterenol‐induced myocardial infarcted rats , 2010, Journal of biochemical and molecular toxicology.

[10]  Mounir Errami,et al.  Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure , 2009, BMC Physiology.

[11]  K. Clarke,et al.  Isoproterenol induces in vivo functional and metabolic abnormalities: similar to those found in the infarcted rat heart. , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[12]  B. Song,et al.  Drug interaction between ethanol and 3,4-methylenedioxymethamphetamine ("ecstasy"). , 2009, Toxicology letters.

[13]  A. Brecher,et al.  Interaction of Biogenic Amine Hormones with Acetaldehyde , 2009, Digestive Diseases and Sciences.

[14]  J. Cockcroft,et al.  The vasodilatory beta-blockers , 2007, Current hypertension reports.

[15]  M. Colado,et al.  Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain , 2006, Psychopharmacology.

[16]  T. Enevoldson Recreational drugs and their neurological consequences , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[17]  A. Brecher 93 – The Effect of Acetaldehyde on Plasma , 2004 .

[18]  M. Naoi,et al.  Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains. , 2004, Neurotoxicology.

[19]  B. Johnson The role of serotonergic agents as treatments for alcoholism. , 2003, Drugs of today.

[20]  H. Yoshida,et al.  Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents , 2003, Journal of the Neurological Sciences.

[21]  A. Brecher,et al.  Short- and long-term effects of acetaldehyde on plasma. , 2002, Alcohol.

[22]  G. Sobue,et al.  A dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl(R)salsolinol, and its oxidation product, 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion, accumulate in the nigro-striatal system of the human brain , 1997, Neuroscience Letters.

[23]  P. Batel The treatment of alcoholism in France. , 1995, Drug and alcohol dependence.

[24]  C. Viscoli,et al.  Randomized controlled trial in alcohol relapse prevention: role of atenolol, alcohol craving, and treatment adherence. , 1994, Journal of substance abuse treatment.

[25]  P. A. Kurup,et al.  Effect of ethanol administration on metabolism of lipids in heart and aorta in isoproterenol induced myocardial infarction in rats. , 1991, Indian journal of experimental biology.

[26]  D. Tuma,et al.  The chemistry of acetaldehyde-protein adducts. , 1991, Alcohol and alcoholism (Oxford, Oxfordshire). Supplement.

[27]  T. Librowski,et al.  The effect of ethanol on the antiarrhythmic action of atenolol. , 1989, Polish journal of pharmacology and pharmacy.

[28]  R. Horwitz,et al.  The efficacy of atenolol in the outpatient management of the alcohol withdrawal syndrome. Results of a randomized clinical trial. , 1989, Archives of internal medicine.

[29]  H. Douard,et al.  Comparison of the anti-anginal efficacy of nicardipine and nifedipine in patients receiving atenolol: a randomized, double-blind, crossover study. , 1989, International journal of cardiology.

[30]  L. Gottlieb The role of beta blockers in alcohol withdrawal syndrome. , 1988, Postgraduate medicine.

[31]  Y. Mizoi,et al.  Effect of acetaldehyde on urinary salsolinol in healthy man after ethanol intake. , 1986, Alcohol.

[32]  M. Adams,et al.  The influences of ethanol and other factors on the excretion of urinary salsolinol in social drinkers , 1985, Pharmacology Biochemistry and Behavior.

[33]  D. Tuma,et al.  Evidence that acetaldehyde irreversibly impairs glycoprotein metabolism in liver slices. , 1977, Gastroenterology.

[34]  G. Stern,et al.  Tetrahydroisoquinoline Alkaloids: in vivo Metabolites of L-Dopa in Man , 1973, Nature.

[35]  D. A. Brown,et al.  The effects of some centrally acting drugs on ganglionic transmission in the cat. , 1964, British journal of pharmacology and chemotherapy.

[36]  J. P. Quilliam,et al.  SOME ACTIONS OF CENTRALLY ACTIVE AND OTHER DRUGS ON THE TRANSMISSION OF SINGLE NERVE IMPULSES THROUGH THE ISOLATED SUPERIOR CERVICAL GANGLION PREPARATION OF THE RABBIT. , 1964, British journal of pharmacology and chemotherapy.

[37]  D. A. Brown,et al.  OBSERVATIONS ON THE MODE OF ACTION OF SOME CENTRAL DEPRESSANT DRUGS ON TRANSMISSION THROUGH THE CAT SUPERIOR CERVICAL GANGLION. , 1964, British journal of pharmacology and chemotherapy.

[38]  H. Fraenkel-conrat,et al.  The reaction of formaldehyde with proteins; cross-linking between amino and primary amide or guanidyl groups. , 1948, Journal of the American Chemical Society.

[39]  H. Fraenkel-conrat,et al.  Reaction of formaldehyde with proteins; cross-linking of amino groups with phenol, imidazole, or indole groups. , 1948, The Journal of biological chemistry.

[40]  H. Fraenkel-conrat,et al.  The Reaction of Formaldehyde with Proteins , 1945 .

[41]  S. Ratner,et al.  The Action of Formaldehyde upon Cysteine , 1937 .

[42]  M. Klapholz ß-BIocker Use for the Stages of Heart Failure , 2022 .